Rheumatoid arthritis (RA) is a destructive, systemic, inflammatory disorder that
characteristically affects small, diarthrodial joints in a progressive, symmetric, and erosive …

Rheumatoid arthritis (RA) is a systemic autoimmune disease affecting 0.5–1% of the
worldwide population. Whilst predominantly causing chronic pain and inflammation in …

Objective To determine the association between novel lifestyle factors on risk of rheumatoid
arthritis (RA)-associated interstitial lung disease (ILD), define the threshold at which smoking …

Purpose of review Rheumatoid arthritis–associated interstitial lung disease (RA-ILD) is one
of the most serious extraarticular RA manifestations. RA-ILD is associated with worse …

Objective. To summarise the epidemiology, risk and prognostic factors, and treatment
landscape of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Methods …

Objective To compare serum anti–malondialdehyde–acetaldehyde (anti‐MAA) antibody
levels and MAA expression in lung tissue from patients with rheumatoid arthritis–associated …

The diagnosis of interstitial lung disease (ILD) requires meticulous evaluation for an
underlying connective tissue disease (CTD), with major implications for prognosis and …

Subclinical and clinical ILD occur frequently in preclinical, early, and established RA and
may play a key role in RA-related autoantibody production and disease progression. Further …

Objective To evaluate the incidence of cardiovascular disease (CVD) morbidity and mortality
over the course of 10 years among the more than 160,000 postmenopausal women in the …

Introduction: Interstitial lung disease (ILD) represents a frequent extra-articular manifestation
of rheumatoid arthritis (RA) deeply impacting both quality of life and overall prognosis. Areas …